UBE2D2 and breast cancer: Previously, circ-UBE2D2 was displayed to be overexpressed in BC; therefore, blocking the circ-UBE2D2 could lead to the inhibition of BC tumorigenesis through targeting miR-1236 or miR-1287 (Wang et al., 2019b).